Related Experiment Video
Updated: Aug 11, 2026
04:14
Laparoscopic Choledochal Cyst Excision and Roux-en-Y Choledochojejunostomy in Adults
Published on: February 28, 2025
Spontaneous neonatal chylothorax treated with octreotide
Sylvia L Y Siu1, David S Y Lam
1Department of Paediatrics and Adolescent Medicine, Tuen Mun Hospital, Tuen Mun, New Territories, Hong Kong, China. siuly8888@hotmail.com
Journal of Paediatrics and Child Health
|February 21, 2006
Summary
Octreotide effectively treated spontaneous neonatal chylothorax, avoiding surgery. This approach may be safer for neonates without cardiac issues, suggesting earlier use of octreotide.
Area of Science:
- Neonatal Medicine
- Pediatric Surgery
- Pharmacology
Background:
- Chylothorax is a frequent cause of respiratory distress in neonates, often necessitating surgical intervention when conservative measures fail.
- Spontaneous neonatal chylothorax presents a significant clinical challenge, with surgery being the traditional next step for refractory cases.
Observation:
- A case of spontaneous neonatal chylothorax was successfully managed without surgery using octreotide.
- The treatment resulted in prompt resolution of the chylothorax with no discernible adverse effects.
Findings:
- Octreotide administration led to the successful resolution of spontaneous neonatal chylothorax, obviating the need for surgical management.
- Literature review suggests that neonates with isolated spontaneous chylothorax may tolerate octreotide better than those with cardiac malformations.
Implications:
- Octreotide represents a viable, non-surgical therapeutic option for spontaneous neonatal chylothorax.
- Consideration of octreotide earlier in the treatment protocol for select neonates, particularly those without major cardiac anomalies, could improve outcomes and reduce surgical risks.
